New Cross Hospital, Royal Wolverhampton NHS Trust, UK.
Department of Cardiology, Super-Speciality Hospital, NSCB Medical College, Jabalpur, MP, India.
Indian Heart J. 2020 Jul-Aug;72(4):225-231. doi: 10.1016/j.ihj.2020.07.013. Epub 2020 Jul 24.
Studies comparing the outcome of percutaneous coronary intervention (PCI) along with optimal medical therapy (OMT) versus OMT alone in treatment of chronic total occlusion (CTO) are limited by observational design, variable follow-up period, diverse clinical outcomes, high drop-out and cross-over rates. This study aims to conduct a meta-analysis of published data of observational as well as randomized studies comparing long term outcomes of PCI+OMT versus OMT alone.
PubMed, Embase and Cochrane databases were systematically reviewed. 15 studies meeting criteria were included in the meta-analysis. The New-castle Ottawa scale was used to appraise the overall quality of the studies. Random-effects model with inverse variance method was undertaken. Major adverse cardiovascular events (MACE) which comprises of cardiac death, myocardial infarction, stroke, and un-planned revascularization were significantly lower in the PCI+OMT group (RR:0.76; 95% CI:0.61 to 0.95; P=<0.00001; I = 85%). All-cause mortality and cardiac death were significantly lower in the PCI+OMT group (P=<0.00001 in both). Myocardial infarction and stroke rates were lower in the PCI+OMT group, however they did not reach statistical significance (P = 0.24, P = 0.15 respectively). Unplanned revascularizations (of any vessel) were also similar in both the groups (P = 0.78, I = 88%).
PCI of CTO is rewarded with better long term outcome, in terms of MACE, all-cause mortality and cardiac death with similar rates of un-planned revascularization.
比较经皮冠状动脉介入治疗(PCI)联合最佳药物治疗(OMT)与单独 OMT 治疗慢性完全闭塞(CTO)的疗效的研究受到观察性设计、随访时间不同、临床结局多样化、高脱落率和交叉率的限制。本研究旨在对比较 PCI+OMT 与单独 OMT 的长期疗效的观察性和随机研究的已发表数据进行荟萃分析。
系统检索了 PubMed、Embase 和 Cochrane 数据库。纳入了符合标准的 15 项研究进行荟萃分析。采用纽卡斯尔-渥太华量表评估研究的总体质量。采用逆方差法进行随机效应模型分析。主要心血管不良事件(MACE)包括心脏死亡、心肌梗死、卒中和非计划性血运重建,PCI+OMT 组显著降低(RR:0.76;95%CI:0.61 至 0.95;P<0.00001;I=85%)。PCI+OMT 组全因死亡率和心脏死亡率也显著降低(均 P<0.00001)。PCI+OMT 组心肌梗死和卒中等发生率较低,但无统计学意义(P=0.24,P=0.15)。两组非计划性血运重建(任何血管)也相似(P=0.78,I=88%)。
CTO 的 PCI 可带来更好的长期疗效,在 MACE、全因死亡率和心脏死亡率方面有获益,且非计划性血运重建的发生率相似。